Article Details

Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock

Retrieved on: 2021-06-15 23:46:45

Tags for this article:

Click the tags to see associated articles and topics

Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock. View article details on hiswai:

Excerpt

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering. JonesTrading Institutional ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo